Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001062993-16-011663
Filing Date
2016-10-07
Accepted
2016-10-07 14:35:36
Documents
2
Period of Report
2016-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A form8ka.htm 8-K/A 7185
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 89914
  Complete submission text file 0001062993-16-011663.txt   98435
Mailing Address SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 V6E 4A4
Business Address SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 V6E 4A4 604-602-1675
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K/A | Act: 34 | File No.: 000-52138 | Film No.: 161927363
SIC: 1000 Metal Mining